Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2644391rdf:typepubmed:Citationlld:pubmed
pubmed-article:2644391lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2644391lifeskim:mentionsumls-concept:C0682323lld:lifeskim
pubmed-article:2644391lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2644391lifeskim:mentionsumls-concept:C0085166lld:lifeskim
pubmed-article:2644391lifeskim:mentionsumls-concept:C0025872lld:lifeskim
pubmed-article:2644391lifeskim:mentionsumls-concept:C1280519lld:lifeskim
pubmed-article:2644391pubmed:issue2lld:pubmed
pubmed-article:2644391pubmed:dateCreated1989-3-22lld:pubmed
pubmed-article:2644391pubmed:abstractTextA randomized, placebo-controlled, double-blind clinical trial was performed to test the hypothesis that a 2-g single dose of metronidazole for male partners of women with bacterial vaginosis was more effective than placebo in improving cure rate and decreasing recurrence rate. In addition, the effectiveness of a 2-g single dose of metronidazole was compared with a seven-day course of 500 mg of metronidazole twice a day in patients with bacterial vaginosis. Statistically significant benefits of partner treatment were noted in the initial cure rate by Gram-stained smear criteria (P less than .01) and in percentage of women with symptoms eight weeks after initiating therapy (P less than .05). The seven-day course of metronidazole was superior to the single-dose regimen in the percentage of patients with clue cells and the percentage of patients with a positive "sniff" test at the first follow-up visit; however, differences in the initial cure rate assessed by clinical criteria and Gram-stained smear criteria were not statistically significant between the two patient treatment regimens. Recurrence rates by Gram-stained smear criteria between patient and partner treatment groups at five and eight weeks after initiation of treatment were also not significantly different between the two patient regimens. Single-dose metronidazole treatment of the sexual partner of women with bacterial vaginosis improves initial bacterial vaginosis cure rates. The seven-day course of metronidazole was not found by statistical analysis to be significantly superior to single-dose therapy when considering initial cure rates by clinical or Gram-stained smear criteria or recurrence rates.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:2644391pubmed:languageenglld:pubmed
pubmed-article:2644391pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2644391pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2644391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2644391pubmed:statusMEDLINElld:pubmed
pubmed-article:2644391pubmed:monthFeblld:pubmed
pubmed-article:2644391pubmed:issn0094-3509lld:pubmed
pubmed-article:2644391pubmed:authorpubmed-author:HermanS JSJlld:pubmed
pubmed-article:2644391pubmed:authorpubmed-author:BergA OAOlld:pubmed
pubmed-article:2644391pubmed:authorpubmed-author:KoepsellT DTDlld:pubmed
pubmed-article:2644391pubmed:authorpubmed-author:MengelM BMBlld:pubmed
pubmed-article:2644391pubmed:authorpubmed-author:HermanD JDJlld:pubmed
pubmed-article:2644391pubmed:authorpubmed-author:HughesV LVLlld:pubmed
pubmed-article:2644391pubmed:authorpubmed-author:WeaverC HCHlld:pubmed
pubmed-article:2644391pubmed:issnTypePrintlld:pubmed
pubmed-article:2644391pubmed:volume28lld:pubmed
pubmed-article:2644391pubmed:ownerNLMlld:pubmed
pubmed-article:2644391pubmed:authorsCompleteYlld:pubmed
pubmed-article:2644391pubmed:pagination163-71lld:pubmed
pubmed-article:2644391pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:meshHeadingpubmed-meshheading:2644391-...lld:pubmed
pubmed-article:2644391pubmed:year1989lld:pubmed
pubmed-article:2644391pubmed:articleTitleThe effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis.lld:pubmed
pubmed-article:2644391pubmed:affiliationDepartment of Family Medicine, School of Medicine, University of Washington, Seattle.lld:pubmed
pubmed-article:2644391pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2644391pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2644391pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:2644391pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2644391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2644391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2644391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2644391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2644391lld:pubmed